Details of the Drug

General Information of Drug (ID: DMB1645)

Drug Name

AMT-101

Indication

Disease Entry	ICD 11	Status	REF
Ulcerative colitis	DD71	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Fusion protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05372939) A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory, Phase 2 Study of the Efficacy and Safety of Oral AMT-101 in Combination With Adalimumab in Subjects With Moderate to Severe Ulcerative Colitis. U.S.National Institutes of Health.